Disease | rheumatoid arthritis |
Symptom | |vascular disease |
Sentences | 64 |
PubMedID- 20735865 | Palomino-morales and colleagues 1 report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
PubMedID- 26082375 | Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 23244227 | Cardiovascular diseases in patients with rheumatoid arthritis. |
PubMedID- 21345288 | Lack of association between retn rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients. |
PubMedID- 23204310 | Atherosclerosis and cardiovascular disease in rheumatoid arthritis. |
PubMedID- 24585741 | Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied. |
PubMedID- 20842919 | Cardiovascular diseases in rheumatoid arthritis. |
PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 20827876 | Cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
PubMedID- 21981268 | Lack of association of il6r rs2228145 and il6st/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 23193471 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. |
PubMedID- 21109513 | Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
PubMedID- 20040642 | Risk factors for cardiovascular disease in rheumatoid arthritis: defining treatment thresholds. |
PubMedID- 26362702 | Objective: to identify risk factors for cardiovascular disease in patients with rheumatoid arthritis (ra). |
PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
PubMedID- 24511540 | For instance, angiopoietin-2 (angpt-2), a marker of endothelial cell activation, has been proposed as a mediator of angiogenesis, which might play an important role in the regulation of endothelial integrity and inflammation and thus is related to severity and cardiovascular disease in patients with rheumatoid arthritis 2. |
PubMedID- 24458537 | The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. |
PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 21905005 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events. |
PubMedID- 24498229 | Conclusion: in observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity. |
PubMedID- 23584985 | Novel risk factors for cardiovascular disease in rheumatoid arthritis. |
PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 22161801 | Results of prior studies have suggested that methotrexate (mtx) may improve vascular disease in patients with psoriasis and rheumatoid arthritis. |
PubMedID- 21520672 | Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
PubMedID- 22249350 | Risk factors for cardiovascular disease in rheumatoid arthritis. |
PubMedID- 21073447 | Lack of association between adipoq rs266729 and adipoq rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. |
PubMedID- 20638217 | Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice. |
PubMedID- 20868308 | Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd). |
PubMedID- 24268008 | Cardiovascular disease in rheumatoid arthritis. |
PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
PubMedID- 21071477 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. |
PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 23079082 | Introduction: recent studies revealed that co-morbidity and mortality due to cardiovascular disease are increased in patients with rheumatoid arthritis (ra) but little is known about factors involved in these manifestations. |
PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 21388351 | Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients. |
PubMedID- 23983474 | The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms. |
PubMedID- 23666917 | Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte). |
PubMedID- 21180241 | Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score frs). |
PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
PubMedID- 24361194 | Usefulness of the ankle-brachial index as a survey method for subclinical vascular disease in patients with rheumatoid arthritis. |
PubMedID- 22513132 | The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized . |
PubMedID- 22808986 | Different techniques have proven to be useful in determining the presence of subclinical cardiovascular disease in patients with rheumatoid arthritis (ra). |
PubMedID- 21608334 | Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis. |
PubMedID- 23899926 | Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. |
PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
Page: 1 2